Aldosterone production is activated in failing ventricle in humans

被引:7
作者
Mizuno, Y
Yoshimura, M
Yasue, H
Sakamoto, T
Ogawa, H
Kugiyama, K
Harada, E
Nakayama, M
Nakamura, S
Ito, T
Shimasaki, Y
Saito, Y
Nakao, K
机构
[1] Kumamoto Aging Res Inst, Div Cardiol, Kumamoto 8608518, Japan
[2] Kumamoto Univ, Sch Med, Dept Cardiovasc Med, Kumamoto, Japan
[3] Kyoto Univ, Grad Sch Med, Dept Med & Clin Sci, Kyoto, Japan
关键词
aldosterone; angiotensin-converting enzyme; angiotensin; B-type natriuretic peptide; ventricles;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Recent reports have indicated that aldosterone is produced in extra-adrenal tissues in animals. The present study was designed to examine whether aldosterone is produced in human heart. Methods and Results-Plasma levels of aldosterone, BNP, and angiotensin-converting enzyme were measured in anterior interventricular vein (AIV), coronary sinus (CS), and aortic root (Ao), respectively, in 20 patients with left ventricular systolic dysfunction (LVSD), 25 patients with LV diastolic dysfunction (LVDD), and 23 control subjects. Aldosterone levels were significantly higher in AIV and CS than Ao in LVSD (98+/-10 versus 72+/-9 pg/mL, P<0.001, and 97+/-11 versus 72+/-9 pg/mL, P<0.001, respectively) and LVDD (87+/-10 versus 71+/-9 pg/mL, P<0.01, and 84+/-10 versus 71+/-9 pg/mL, P<0.01, respectively) groups, but no differences were observed in levels for these sites in the control group. Levels of ACE activity and BNP also were higher in AIV than Ao in both LV dysfunction groups. The difference in aldosterone levels between AIV and Ao and those in BNP and angiotensin-converting enzyme had a significant positive correlation with LVEDP and a significant negative correlation with LV ejection fraction in the LVSD group. Conclusions-Production of aldosterone, angiotensin-converting enzyme, and BNP are activated in failing human ventricle in proportion to severity.
引用
收藏
页码:72 / 77
页数:6
相关论文
共 31 条
[1]  
ATARASHI K, 1984, SCIENCE, V224, P992, DOI 10.1126/science.6326267
[2]   EFFECTS OF ADDING SPIRONOLACTONE TO AN ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR IN CHRONIC CONGESTIVE-HEART-FAILURE SECONDARY TO CORONARY-ARTERY DISEASE [J].
BARR, CS ;
LANG, CC ;
HANSON, J ;
ARNOTT, M ;
KENNEDY, N ;
STRUTHERS, AD .
AMERICAN JOURNAL OF CARDIOLOGY, 1995, 76 (17) :1259-1265
[3]   Angiotensin II and potassium regulate human CYP11B2 transcription through common cis-elements [J].
Clyne, CD ;
Zhang, Y ;
Slutsker, L ;
Mathis, JM ;
White, PC ;
Rainey, WE .
MOLECULAR ENDOCRINOLOGY, 1997, 11 (05) :638-649
[4]  
DZAU VJ, 1988, CIRCULATION, V77, P1
[5]   MINERALOCORTICOID ACTION - TARGET TISSUE-SPECIFICITY IS ENZYME, NOT RECEPTOR, MEDIATED [J].
FUNDER, JW ;
PEARCE, PT ;
SMITH, R ;
SMITH, AI .
SCIENCE, 1988, 242 (4878) :583-585
[6]   Aldosterone biosynthesis in the rat brain [J].
GomezSanchez, CE ;
Zhou, MY ;
Cozza, EN ;
Morita, H ;
Foecking, MF ;
GomezSanchez, EP .
ENDOCRINOLOGY, 1997, 138 (08) :3369-3373
[7]  
HATAKEYAMA H, 1994, J BIOL CHEM, V269, P24316
[8]  
KASAHARA Y, 1981, CLIN CHEM, V27, P1922
[9]  
KONO M, 1993, KAKU IGAKU, V13, P2
[10]   INHIBITION OF ALDOSTERONE PRODUCTION IN THE ADRENAL GLOMERULOSA BY ATRIAL NATRIURETIC FACTOR [J].
KUDO, T ;
BAIRD, A .
NATURE, 1984, 312 (5996) :756-757